일본의 재생의료 시장(2025-2029년)

The regenerative medicine market in Japan is forecasted to grow by USD 4600.6 million during 2024-2029, accelerating at a CAGR of 21.2% during the forecast period. The report on the regenerative medicine market in Japan provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing adoption of STEM cell therapy, rising prevalence of chronic diseases, and increasing aging population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's regenerative medicine market in Japan is segmented as below:

By Application

• Oncology
• Musculoskeletal
• Dermatology
• Others

By Technology

• Cell and tissue-based
• Gene therapy

By End-user

• Hospitals and clinics
• Speciality centers
• Government and research institutes

By Geographical Landscape

• APAC

This study identifies the increasing number of clinical trials as one of the prime reasons driving the regenerative medicine market in Japan growth during the next few years. Also, growing mergers and acquisitions among companies and development of induced pluripotent STEM cells will lead to sizable demand in the market.

The report on the regenerative medicine market in Japan covers the following areas:

• Regenerative Medicine Market in Japan sizing
• Regenerative Medicine Market in Japan forecast
• Regenerative Medicine Market in Japan industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading regenerative medicine market in Japan vendors that include Astellas Pharma Inc., Becton Dickinson and Co., CellSeed Inc., Cellusion Inc., Cyfuse Biomedical K.K., F. Hoffmann La Roche Ltd., FUJIFILM Holdings Corp., iHeart Japan Corp., Japan Tissue Engineering Co. Ltd., JCR Pharmaceticals Co. Ltd., Nikon Corp., ROHTO Pharmaceutical Co. Ltd., Sumitomo Pharma Co. Ltd., Takara Bio Inc., Takeda Pharmaceutical Co. Ltd., Terumo Corp., and Yokogawa Electric Corp.. Also, the regenerative medicine market in Japan analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Country Market Characteristics
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan: Year-over-year growth 2024-2029 (%)
  • Data Table on Japan: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Regenerative Medicine Market in Japan 2019 - 2023
  • Historic Market Size - Data Table on Regenerative Medicine Market in Japan 2019 - 2023 ($ million)
• 5.2 Application segment analysis 2019 - 2023
  • Historic Market Size - Application Segment 2019 - 2023 ($ million)
• 5.3 Technology segment analysis 2019 - 2023
  • Historic Market Size - Technology Segment 2019 - 2023 ($ million)
• 5.4 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Regenerative Medicine Market in Japan

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Application

• 8.1 Market segments
  • Chart on Application - Market share 2024-2029 (%)
  • Data Table on Application - Market share 2024-2029 (%)
• 8.2 Comparison by Application
  • Chart on Comparison by Application
  • Data Table on Comparison by Application
• 8.3 Oncology - Market size and forecast 2024-2029
  • Chart on Oncology - Market size and forecast 2024-2029 ($ million)
  • Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
  • Chart on Oncology - Year-over-year growth 2024-2029 (%)
  • Data Table on Oncology - Year-over-year growth 2024-2029 (%)
• 8.4 Musculoskeletal - Market size and forecast 2024-2029
  • Chart on Musculoskeletal - Market size and forecast 2024-2029 ($ million)
  • Data Table on Musculoskeletal - Market size and forecast 2024-2029 ($ million)
  • Chart on Musculoskeletal - Year-over-year growth 2024-2029 (%)
  • Data Table on Musculoskeletal - Year-over-year growth 2024-2029 (%)
• 8.5 Dermatology - Market size and forecast 2024-2029
  • Chart on Dermatology - Market size and forecast 2024-2029 ($ million)
  • Data Table on Dermatology - Market size and forecast 2024-2029 ($ million)
  • Chart on Dermatology - Year-over-year growth 2024-2029 (%)
  • Data Table on Dermatology - Year-over-year growth 2024-2029 (%)
• 8.6 Others - Market size and forecast 2024-2029
  • Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Chart on Others - Year-over-year growth 2024-2029 (%)
  • Data Table on Others - Year-over-year growth 2024-2029 (%)
• 8.7 Market opportunity by Application
  • Market opportunity by Application ($ million)
  • Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by Technology

• 9.1 Market segments
  • Chart on Technology - Market share 2024-2029 (%)
  • Data Table on Technology - Market share 2024-2029 (%)
• 9.2 Comparison by Technology
  • Chart on Comparison by Technology
  • Data Table on Comparison by Technology
• 9.3 Cell and tissue-based - Market size and forecast 2024-2029
  • Chart on Cell and tissue-based - Market size and forecast 2024-2029 ($ million)
  • Data Table on Cell and tissue-based - Market size and forecast 2024-2029 ($ million)
  • Chart on Cell and tissue-based - Year-over-year growth 2024-2029 (%)
  • Data Table on Cell and tissue-based - Year-over-year growth 2024-2029 (%)
• 9.4 Gene therapy - Market size and forecast 2024-2029
  • Chart on Gene therapy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Gene therapy - Market size and forecast 2024-2029 ($ million)
  • Chart on Gene therapy - Year-over-year growth 2024-2029 (%)
  • Data Table on Gene therapy - Year-over-year growth 2024-2029 (%)
• 9.5 Market opportunity by Technology
  • Market opportunity by Technology ($ million)
  • Data Table on Market opportunity by Technology ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
  • Chart on End-user - Market share 2024-2029 (%)
  • Data Table on End-user - Market share 2024-2029 (%)
• 10.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 10.3 Hospitals and clinics - Market size and forecast 2024-2029
  • Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
  • Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
  • Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
  • Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
• 10.4 Speciality centers - Market size and forecast 2024-2029
  • Chart on Speciality centers - Market size and forecast 2024-2029 ($ million)
  • Data Table on Speciality centers - Market size and forecast 2024-2029 ($ million)
  • Chart on Speciality centers - Year-over-year growth 2024-2029 (%)
  • Data Table on Speciality centers - Year-over-year growth 2024-2029 (%)
• 10.5 Government and research institutes - Market size and forecast 2024-2029
  • Chart on Government and research institutes - Market size and forecast 2024-2029 ($ million)
  • Data Table on Government and research institutes - Market size and forecast 2024-2029 ($ million)
  • Chart on Government and research institutes - Year-over-year growth 2024-2029 (%)
  • Data Table on Government and research institutes - Year-over-year growth 2024-2029 (%)
• 10.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Drivers, Challenges, and Opportunity/Restraints

• 12.1 Market drivers
• 12.2 Market challenges
• 12.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 12.4 Market opportunities/restraints

13 Competitive Landscape

• 13.1 Overview
• 13.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 13.3 Landscape disruption
  • Overview on factors of disruption
• 13.4 Industry risks
  • Impact of key risks on business

14 Competitive Analysis

• 14.1 Companies profiled
  • Companies covered
• 14.2 Company ranking index
  • Company ranking index
• 14.3 Market positioning of companies
  • Matrix on companies position and classification
• 14.4 Astellas Pharma Inc.
  • Astellas Pharma Inc. - Overview
  • Astellas Pharma Inc. - Product / Service
  • Astellas Pharma Inc. - Key offerings
  • SWOT
• 14.5 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 14.6 CellSeed Inc.
  • CellSeed Inc. - Overview
  • CellSeed Inc. - Product / Service
  • CellSeed Inc. - Key offerings
  • SWOT
• 14.7 Cyfuse Biomedical K.K.
  • Cyfuse Biomedical K.K. - Overview
  • Cyfuse Biomedical K.K. - Product / Service
  • Cyfuse Biomedical K.K. - Key offerings
  • SWOT
• 14.8 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 14.9 FUJIFILM Holdings Corp.
  • FUJIFILM Holdings Corp. - Overview
  • FUJIFILM Holdings Corp. - Business segments
  • FUJIFILM Holdings Corp. - Key news
  • FUJIFILM Holdings Corp. - Key offerings
  • FUJIFILM Holdings Corp. - Segment focus
  • SWOT
• 14.10 iHeart Japan Corp.
  • iHeart Japan Corp. - Overview
  • iHeart Japan Corp. - Product / Service
  • iHeart Japan Corp. - Key offerings
  • SWOT
• 14.11 JCR Pharmaceticals Co. Ltd.
  • JCR Pharmaceticals Co. Ltd. - Overview
  • JCR Pharmaceticals Co. Ltd. - Product / Service
  • JCR Pharmaceticals Co. Ltd. - Key offerings
  • SWOT
• 14.12 Nikon Corp.
  • Nikon Corp. - Overview
  • Nikon Corp. - Business segments
  • Nikon Corp. - Key offerings
  • Nikon Corp. - Segment focus
  • SWOT
• 14.13 ROHTO Pharmaceutical Co. Ltd.
  • ROHTO Pharmaceutical Co. Ltd. - Overview
  • ROHTO Pharmaceutical Co. Ltd. - Business segments
  • ROHTO Pharmaceutical Co. Ltd. - Key offerings
  • ROHTO Pharmaceutical Co. Ltd. - Segment focus
  • SWOT
• 14.14 Sumitomo Pharma Co. Ltd.
  • Sumitomo Pharma Co. Ltd. - Overview
  • Sumitomo Pharma Co. Ltd. - Business segments
  • Sumitomo Pharma Co. Ltd. - Key offerings
  • Sumitomo Pharma Co. Ltd. - Segment focus
  • SWOT
• 14.15 Takara Bio Inc.
  • Takara Bio Inc. - Overview
  • Takara Bio Inc. - Product / Service
  • Takara Bio Inc. - Key news
  • Takara Bio Inc. - Key offerings
  • SWOT
• 14.16 Takeda Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Takeda Pharmaceutical Co. Ltd. - Key news
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
  • SWOT
• 14.17 Terumo Corp.
  • Terumo Corp. - Overview
  • Terumo Corp. - Business segments
  • Terumo Corp. - Key news
  • Terumo Corp. - Key offerings
  • Terumo Corp. - Segment focus
  • SWOT
• 14.18 Yokogawa Electric Corp.
  • Yokogawa Electric Corp. - Overview
  • Yokogawa Electric Corp. - Business segments
  • Yokogawa Electric Corp. - Key news
  • Yokogawa Electric Corp. - Key offerings
  • Yokogawa Electric Corp. - Segment focus
  • SWOT

15 Appendix

• 15.1 Scope of the report
• 15.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 15.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 15.4 Research methodology
  • Research methodology
• 15.5 Data procurement
  • Information sources
• 15.6 Data validation
  • Data validation
• 15.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 15.8 Data synthesis
  • Data synthesis
• 15.9 360 degree market analysis
  • 360 degree market analysis
• 15.10 List of abbreviations
  • List of abbreviations